Free Trial

Outset Medical (OM) Stock Forecast & Price Target

$3.75
+0.06 (+1.63%)
(As of 11:50 AM ET)

Outset Medical - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$5.42
44.44% Upside
High Forecast$6.00
Average Forecast$5.42
Low Forecast$3.00
TypeCurrent Forecast
7/3/23 to 7/2/24
1 Month Ago
6/3/23 to 6/2/24
3 Months Ago
4/4/23 to 4/3/24
1 Year Ago
7/3/22 to 7/3/23
Consensus Rating
Moderate Buy
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
3 Buy rating(s)
1 Buy rating(s)
2 Buy rating(s)
Hold
1 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$5.42$5.42$5.13$24.50
Forecasted Upside44.44% Upside27.45% Upside-4.70% Downside33.06% Upside

OM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

OM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Outset Medical Stock vs. The Competition

TypeOutset MedicalMedical CompaniesS&P 500
Consensus Rating Score
2.50
2.70
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside46.79% Upside833.91% Upside12.45% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/21/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Singh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Perform ➝ Outperform$5.00 ➝ $6.00+67.36%
4/8/2024BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$6.00+192.68%
4/5/2024CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy$6.00+209.28%
12/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$5.00 ➝ $5.50-3.34%
10/13/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$26.00 ➝ $6.00+46.34%
10/13/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Underperform$32.00 ➝ $3.00-55.69%
URGENT: I’m typing this as fast as I can. (Ad)

I was just informed about something very unsettling… The U.S. Federal Reserve’s computers were allegedly hacked recently. The perpetrators claim to have stolen 33 Terabytes of data, including critical banking information of Americans … Which means all of your banking details could already be in their hands.

Click here and follow the three simple steps Martin shares to protect your savings
5/31/2023888
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMaintains
11/15/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$22.00+12.65%
11/9/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$34.00 ➝ $29.00+84.83%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 12:08 PM ET.

OM Forecast - Frequently Asked Questions

What is Outset Medical's stock forecast and purchase recommendation?

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Outset Medical is $5.42, with a high forecast of $6.00 and a low forecast of $3.00. The consensus rating for Outset Medical stock is Moderate Buy based on the current 1 sell rating, 1 hold rating and 4 buy ratings for OM. Learn more on OM's analyst rating history.

Do Wall Street analysts like Outset Medical more than its competitors?

Analysts like Outset Medical less than other "medical" companies. The consensus rating score for Outset Medical is 2.50 while the average consensus rating score for "medical" companies is 2.70. Learn more on how OM compares to other companies.

Is Outset Medical being upgraded by Wall Street analysts?

Over the previous 90 days, Outset Medical's stock had 2 upgrades by analysts.

Does Outset Medical's stock price have much upside?

According to analysts, Outset Medical's stock has a predicted upside of 34.66% based on their 12-month stock forecasts.

What analysts cover Outset Medical?

Outset Medical has been rated by research analysts at BTIG Research, CL King, and Royal Bank of Canada in the past 90 days.


This page (NASDAQ:OM) was last updated on 7/2/2024 by MarketBeat.com Staff

From Our Partners